Bacterial Vaginosis Rx Drug Market

Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria.
Bacterial Vaginosis Rx Drug Market contains market size and forecasts of Bacterial Vaginosis Rx Drug in global, including the following market information:
Global Bacterial Vaginosis Rx Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bacterial Vaginosis Rx Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Bacterial Vaginosis Rx Drug companies in 2021 (%)
The global Bacterial Vaginosis Rx Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pill Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bacterial Vaginosis Rx Drug include Bayer, Pfizer, Sanofi, Piramal, Abbott, Galderma, Mission, Alkem and Xiuzheng, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bacterial Vaginosis Rx Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bacterial Vaginosis Rx Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bacterial Vaginosis Rx Drug Market Segment Percentages, by Type, 2021 (%)
Pill
Gel
Cream
Other
Global Bacterial Vaginosis Rx Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bacterial Vaginosis Rx Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Bacterial Vaginosis Rx Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bacterial Vaginosis Rx Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bacterial Vaginosis Rx Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bacterial Vaginosis Rx Drug revenues share in global market, 2021 (%)
Key companies Bacterial Vaginosis Rx Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Bacterial Vaginosis Rx Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Pfizer
Sanofi
Piramal
Abbott
Galderma
Mission
Alkem
Xiuzheng
Teva
Perrigo
West-Ward
HPGC
Yunnan Baiyao
Starpharma
Novel
Edenvridge